학술논문
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, November 2023, 194)
Subject
Language
English
ISSN
18790852
09598049
09598049